Untranslated regions of thyroid hormone receptor beta 1 mRNA are impaired in human clear cell renal cell carcinoma
- PMID: 20691260
- DOI: 10.1016/j.bbadis.2010.07.025
Untranslated regions of thyroid hormone receptor beta 1 mRNA are impaired in human clear cell renal cell carcinoma
Abstract
Thyroid hormone receptor β1 (TRβ1) is a hormone-dependent transcription factor activated by 3,5,3'-l-triiodothyronine (T3). TRβ1 functions as a tumor suppressor and disturbances of the THRB gene are frequent findings in cancer. Translational control mediated by untranslated regions (UTRs) regulates cell proliferation, metabolism and responses to cellular stress, processes that are involved in carcinogenesis. We hypothesized that reduced TRβ1 expression in clear cell renal cell cancer (ccRCC) results from regulatory effects of TRβ1 5' and 3'UTRs on protein translation. We determined TRβ1 expression and alternative splicing of TRβ1 5' and 3'UTRs in ccRCC and control tissue together with expression of the type 1 deiodinase enzyme (coded by DIO1, a TRβ1 target gene). Tissue concentrations of T3 (which are generated in part by D1) and expression of miRNA-204 (an mRNA inhibitor for which a putative interaction site was identified in the TRβ1 3'UTR) were also determined. TRβ1 mRNA and protein levels were reduced by 70% and 91% in ccRCC and accompanied by absent D1 protein, a 58% reduction in tissue T3 concentration and 2-fold increase in miRNA-204. Structural analysis of TRβ1 UTR variants indicated that reduced TRβ1 expression may be maintained in ccRCC by posttranscriptional mechanisms involving 5'UTRs and miRNA-204. The tumor suppressor activity of TRβ1 indicates that reduced TRβ1 expression and tissue hypothyroidism in ccRCC tumors is likely to be involved in the process of carcinogenesis or in maintaining a proliferative advantage to malignant cells.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
-
MiR-224 targets the 3'UTR of type 1 5'-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer.PLoS One. 2011;6(9):e24541. doi: 10.1371/journal.pone.0024541. Epub 2011 Sep 2. PLoS One. 2011. PMID: 21912701 Free PMC article.
-
Regulatory feedback loop between T3 and microRNAs in renal cancer.Mol Cell Endocrinol. 2014 Mar 25;384(1-2):61-70. doi: 10.1016/j.mce.2014.01.006. Epub 2014 Jan 17. Mol Cell Endocrinol. 2014. PMID: 24440748
-
Multiple messenger ribonucleic acid variants regulate cell-specific expression of human thyroid hormone receptor beta1.Mol Endocrinol. 2004 Jul;18(7):1631-42. doi: 10.1210/me.2003-0346. Epub 2004 Apr 22. Mol Endocrinol. 2004. PMID: 15105435
-
Epigenetic regulation of thyroid hormone receptor beta in renal cancer.PLoS One. 2014 May 21;9(5):e97624. doi: 10.1371/journal.pone.0097624. eCollection 2014. PLoS One. 2014. PMID: 24849932 Free PMC article.
-
The Untranslated Regions of mRNAs in Cancer.Trends Cancer. 2019 Apr;5(4):245-262. doi: 10.1016/j.trecan.2019.02.011. Epub 2019 Mar 22. Trends Cancer. 2019. PMID: 30961831 Free PMC article. Review.
Cited by
-
The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer.Mol Oncol. 2024 Sep;18(9):2298-2313. doi: 10.1002/1878-0261.13612. Epub 2024 Mar 1. Mol Oncol. 2024. PMID: 38429887 Free PMC article.
-
LRRC19-A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on Datamining.Genes (Basel). 2020 Apr 17;11(4):440. doi: 10.3390/genes11040440. Genes (Basel). 2020. PMID: 32316597 Free PMC article.
-
Iodothyronine deiodinases and cancer.J Endocrinol Invest. 2011 Oct;34(9):716-28. doi: 10.3275/7754. Epub 2011 May 27. J Endocrinol Invest. 2011. PMID: 21623154 Review.
-
Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC).J Clin Endocrinol Metab. 2011 Mar;96(3):E546-53. doi: 10.1210/jc.2010-1594. Epub 2010 Dec 15. J Clin Endocrinol Metab. 2011. PMID: 21159845 Free PMC article.
-
Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.PLoS One. 2010 Oct 27;5(10):e13690. doi: 10.1371/journal.pone.0013690. PLoS One. 2010. PMID: 21082031 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical